Completed OBSERVATIONAL NCT02492581

Use of Selincro and Impact on Usual Practice (USE-PACT)

Sponsor: Lundbeck France

Interventions Nalmefene

Updated 7 times since 2017 Last updated: May 11, 2018 Started: Feb 29, 2016 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alcohol Dependence, this trial is completed. The trial is conducted by Lundbeck France and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

Status: Active Not Recruiting → Completed
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None

▶ Show 2 earlier versions

May 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2017 — May 2017 [monthly]

Recruiting NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lundbeck France
University of Bordeaux

Data source: University of Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France